- Home
- PVLA vs DCOM Comparison
PVLA vs DCOM Comparison
Compare PVLA & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVLA | DCOM |
|---|---|---|
| Founded | 2015 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PVLA | DCOM |
|---|---|---|
| Price | $130.71 | $38.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $228.93 | $46.00 |
| AVG Volume (30 Days) | 191.6K | ★ 303.7K |
| Earning Date | 11-10-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | 52.62 | ★ 329.09 |
| EPS | N/A | ★ 1.49 |
| Revenue | ★ $42,810,000.00 | $19,907,000.00 |
| Revenue This Year | N/A | $14.41 |
| Revenue Next Year | N/A | $10.39 |
| P/E Ratio | ★ N/A | $25.84 |
| Revenue Growth | ★ 65.28 | 19.03 |
| 52 Week Low | $68.96 | $25.63 |
| 52 Week High | $161.38 | $41.97 |
Technical Indicators
Market Signals| Indicator | PVLA | DCOM |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 34.34 |
| Support Level | $109.68 | $37.51 |
| Resistance Level | $135.23 | $41.45 |
| Average True Range (ATR) | 7.07 | 0.71 |
| MACD | -0.56 | -0.16 |
| Stochastic Oscillator | 21.32 | 12.50 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
About DCOM Dime Community Bancshares Inc.
Dime Commercial Bancshares Inc is the holding company for Dime Commercial Bank, a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island.